We’re excited to share that Merck’s new monoclonal antibody, Enflonsia™, is now part of the CPP portfolio. This addition reflects the…
Merck
October 8, 2024
![Semi-Annual Rebates]()
CPP Members, please keep an eye out for your CPP semi-annual rebate that will be coming by mail this month!…
February 19, 2024
![CDC 2025 schedule]()
Measles is on the rise across the world and country. As flu, COVID and RSV continue to be a concern,…